1919 NEUTROPHIL-TO-LYMPHOCYTE RATIO REDUCTION AS A SURROGATE MARKER OF PROGNOSIS IN PATIENTS WITH METASTATIC CLEAR CELL RENAL CELL CARCINOMA RECEIVING SUNITINIB AS FIRST-LINE THERAPY
Published 2013 View Full Article
Published 2013 View Full Article
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now